146 related articles for article (PubMed ID: 10602043)
21. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA
J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950
[TBL] [Abstract][Full Text] [Related]
22. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
23. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
24. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions.
Pollack M; Ohl CA; Golenbock DT; Di Padova F; Wahl LM; Koles NL; Guelde G; Monks BG
J Immunol; 1997 Oct; 159(7):3519-30. PubMed ID: 9317151
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
27. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
Shuto T; Kato K; Mori Y; Viriyakosol S; Oba M; Furuta T; Okiyoneda T; Arima H; Suico MA; Kai H
Biochem Biophys Res Commun; 2005 Dec; 338(3):1402-9. PubMed ID: 16263085
[TBL] [Abstract][Full Text] [Related]
28. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
29. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
[TBL] [Abstract][Full Text] [Related]
30. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
31. CD11/CD18 and CD14 share a common lipid A signaling pathway.
Ingalls RR; Monks BG; Savedra R; Christ WJ; Delude RL; Medvedev AE; Espevik T; Golenbock DT
J Immunol; 1998 Nov; 161(10):5413-20. PubMed ID: 9820516
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
Wurfel MM; Wright SD
J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463
[TBL] [Abstract][Full Text] [Related]
33. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2.
Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman E; Lichenstein HS; Wurfel MM; Miller DS; Johnson DA; Kelley M; Busse LA; Zukowski MM; Wright SD
J Exp Med; 1994 Jan; 179(1):269-77. PubMed ID: 7505800
[TBL] [Abstract][Full Text] [Related]
35. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity.
Delude RL; Fenton MJ; Savedra R; Perera PY; Vogel SN; Thieringer R; Golenbock DT
J Biol Chem; 1994 Sep; 269(35):22253-60. PubMed ID: 7520914
[TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
Haziot A; Tsuberi BZ; Goyert SM
J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797
[TBL] [Abstract][Full Text] [Related]
38. Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions.
Asai Y; Hashimoto M; Ogawa T
Eur J Immunol; 2003 Nov; 33(11):3196-204. PubMed ID: 14579288
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
40. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
